Combined Treatment Fkt-Botulinum Toxin Type A (Btx-A) in Patients with Strumpell-Lorrain Disease

E-ISSN： 1873-4286|22|6|758-763

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.6, 2016-02, pp. : 758-763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of the Treatment with Botulinum Toxin Type A (BTX-A) in the Management of the Spasticity in Patients with Amyotrophic Lateral Sclerosis (ALS)

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Botulinum toxin type A for the treatment of migraine

By Aurora Sheena

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite

Botulinum toxin type B: a new injectable treatment for cervical dystonia

By Brashear Allison

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2191-2199

Informa Healthcare

Access to resources Recommend Favorite

Botulinum Toxin Type A for Facial Rejuvenation

By LOWE NICHOLAS J.

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1216-1218

Elsevier

Access to resources Recommend Favorite

Botulinum toxin A for the treatment of cervical dystonia

By Zesiewicz Theresa A Stamey William Sullivan Kelly L Hauser Robert A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 2017-2024

Informa Healthcare

Access to resources Recommend Favorite